Product Code: BT 2486
"Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024"
The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing research funding, and the growth in the number of drug discovery activities. Emerging economies with growing R&D expenditures are also expected to provide opportunities for the growth of the market.
"Services exhibited the highest CAGR over the forecast period."
By product & service, the cell-based assays market is segmented into consumables, instruments and services. Over the forecast period, the services segment accounted for the highest CAGR. The increased R&D investments and technological innovations in supportive processes such as high-throughput screening is driving the growth of this product & service segment.
"Basic research held the significant share in the cell-based assays market in 2019"
On the basis of application, the cell-based assays market is segmented into drug discovery, basic research and other research such as quality check among others. In 2019, the drug discovery segment accounted for the largest share of the cell-based assays market. The large share of this segment can be attributed to the rising adoption of in vitro testing over animal testing and increasing in R&D spending by biopharmaceutical companies.
"Asia Pacific exhibited the highest CAGR over the forecast period"
North America, which includes the US and Canada, accounted for the largest share of the cell-based assays market. The large share of this market segment can be attributed to the increasing drug discovery activities by pharmaceutical and biotechnology companies. In addition to this, consolidations between academic and government institutes with biopharmaceutical companies in the region are also driving the growth of this market.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)
Some of the major players in this market include: Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).
Research Coverage:
This report studies the cell-based assays market based on products, applications, end users, and regions. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell-based assays market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the cell-based assays offered by the top 10 players in the cell-based assays market. The report analyzes the cell-based assays market by product, , end user, application, and region
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell-based assays across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell-based assays market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.2.1 MARKETS COVERED
- 1.2.2 YEARS CONSIDERED FOR THE STUDY
- 1.3 CURRENCY
- 1.4 LIMITATIONS
- 1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key Data from Secondary Sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key data from primary sources
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.2 TOP-DOWN APPROACH
- 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 CELL-BASED ASSAYS: MARKET OVERVIEW
- 4.2 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE AND APPLICATION (2018)
- 4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Growing preference for cell-based assays
- 5.2.1.2 Growing research funding
- 5.2.1.3 Growth in the number of drug discovery activities
- 5.2.2 RESTRAINT
- 5.2.2.1 High cost of instruments and restrictions on reagent use
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 High-growth Asian countries
- 5.2.3.2 Application of novel cell-based assays in cancer research
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE
- 6.1 INTRODUCTION
- 6.2 CONSUMABLES
- 6.2.1 REAGENTS
- 6.2.1.1 Reagents have widespread usage in life sciences due to their application in immunology research, disease research, and cancer diagnostics
- 6.2.2 ASSAY KITS
- 6.2.2.1 Reporter gene assays
- 6.2.2.1.1 Reporter gene assays can be used with limited resources for the establishment of HTS platforms, presenting opportunities for small laboratories with limited resources
- 6.2.2.2 Second messenger assays
- 6.2.2.2.1 Second messenger assays allow the detection and characterization of all compound classes-a key driver for market growth
- 6.2.2.3 Cell growth assays
- 6.2.2.3.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth
- 6.2.2.4 Cell death assays
- 6.2.2.4.1 Cell death quantification is essential in drug development to identify the manner in which potential drugs could inhibit or enhance molecular targets-a key factor propelling market demand
- 6.2.2.5 Other assay kits
- 6.2.3 PROBES & LABELS
- 6.2.3.1 Effective labeling of cells helps in studying cellular events in a spatial and temporal context-a key factor driving the demand for probes and labels
- 6.2.4 MICROPLATES
- 6.2.4.1 Increasing demand for cell-based assays in drug discovery, basic research, and preclinical safety studies is encouraging the consumption of microplates
- 6.2.5 CELL LINES
- 6.2.5.1 Immortalized cell lines
- 6.2.5.1.1 Advantages of immortalized cell lines creating a demand for these cell lines over primary and stem cell lines
- 6.2.5.2 Primary cell lines
- 6.2.5.2.1 Primary cell lines are more sensitive as compared to immortalized cell lines-a key factor limiting market growth
- 6.2.5.3 Stem cell lines
- 6.2.5.3.1 Stem cell lines are alternative methodologies to address the cellularity issues that involve the directed differentiation of embryonic stem (ES) cells or induced pluripotent stem cells (iPS)
- 6.2.6 OTHER CONSUMABLES
- 6.3 INSTRUMENTS
- 6.3.1 BIOTECHNOLOGY COMPANIES AIM TO STREAMLINE THEIR WORKFLOWS TO IMPROVE PRODUCTIVITY AND REDUCE COSTS, WHICH WILL DRIVE THE GROWTH OF THE INSTRUMENTS MARKET
- 6.4 SERVICES
7 CELL-BASED ASSAYS MARKET, BY APPLICATION
- 7.1 INTRODUCTION
- 7.2 DRUG DISCOVERY
- 7.2.1 TOXICITY STUDIES
- 7.2.1.1 Increasing adoption of high-content screening for evaluating cytotoxicity is a factor stimulating the use of cell-based assays for toxicity studies
- 7.2.2 PHARMACOKINETIC STUDIES
- 7.2.2.1 Demand for ADME studies to rise due to the growing need for improved clinical success-a major factor driving growth
- 7.2.3 PHARMACODYNAMIC STUDIES
- 7.2.3.1 Increasing number of pharmacodynamics studies globally to drive growth in the cell-based assays market
- 7.3 BASIC RESEARCH
- 7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
- 7.4 OTHER APPLICATIONS
8 CELL-BASED ASSAYS MARKET, BY END USER
- 8.1 INTRODUCTION
- 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 8.2.1 THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT IS PRIMARILY DRIVEN BY THE GROWTH IN THE NUMBER OF R&D ACTIVITIES
- 8.3 ACADEMIC & GOVERNMENT INSTITUTES
- 8.3.1 INCREASING INTEREST OF ACADEMIC INSTITUTIONS TO DEVELOP ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
- 8.4 CONTRACT RESEARCH ORGANIZATIONS
- 8.4.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS
9 CELL-BASED ASSAYS MARKET, BY REGION
- 9.1 INTRODUCTION
- 9.2 NORTH AMERICA
- 9.3 EUROPE
- 9.3.1 UK
- 9.3.2 GERMANY
- 9.3.3 FRANCE
- 9.3.4 REST OF EUROPE
- 9.4 ASIA PACIFIC
- 9.4.1 CHINA
- 9.4.2 JAPAN
- 9.4.3 INDIA
- 9.4.4 REST OF ASIA PACIFIC
- 9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
- 10.1 OVERVIEW
- 10.2 MARKET RANKING ANALYSIS, 2017
- 10.2.1 CELL-BASED ASSAYS MARKET RANKING, BY KEY PLAYER, 2017
- 10.3 KEY STRATEGIES
- 10.3.1 PRODUCT LAUNCHES, 2015-2018
- 10.3.2 EXPANSIONS, 2015-2018
- 10.3.3 COLLABORATIONS, 2015-2018:
- 10.3.4 ACQUISITIONS, 2015-2018
- 10.4 COMPETITIVE LEADERSHIP MAPPING (2017)
- 10.5 VISIONARY LEADERS
- 10.6 INNOVATORS
- 10.6.1 DYNAMIC DIFFERENTIATORS
- 10.6.2 EMERGING COMPANIES
- 10.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
- 10.7.1 PROGRESSIVE COMPANIES
- 10.7.2 STARTING BLOCKS
- 10.7.3 RESPONSIVE COMPANIES
- 10.7.4 DYNAMIC COMPANIES
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
- 11.1 THERMO FISHER SCIENTIFIC INC.
- 11.2 DANAHER CORPORATION
- 11.3 BECTON, DICKINSON AND COMPANY
- 11.4 GE HEALTHCARE
- 11.5 MERCK KGAA
- 11.6 LONZA GROUP LTD.
- 11.7 PERKINELMER, INC.
- 11.8 CHARLES RIVER LABORATORIES, INC.
- 11.9 CELL SIGNALING TECHNOLOGY, INC.
- 11.10 PROMEGA CORPORATION
- 11.11 CISBIO
- 11.12 CELL BIOLABS, INC.
Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
- 12.1 INSIGHTS OF INDUSTRY EXPERTS
- 12.2 DISCUSSION GUIDE
- 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 12.4 AVAILABLE CUSTOMIZATIONS
- 12.5 RELATED REPORTS
- 12.6 AUTHOR DETAILS
